Bristol Myers Squibb - 51 Year Stock Price History | BMY
Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits. The latest closing stock price for Bristol Myers Squibb as of February 06, 2023 is 74.53.
- The all-time high Bristol Myers Squibb stock closing price was 80.49 on December 02, 2022.
- The Bristol Myers Squibb 52-week high stock price is 81.44, which is 9.3% above the current share price.
- The Bristol Myers Squibb 52-week low stock price is 65.62, which is 12% below the current share price.
- The average Bristol Myers Squibb stock price for the last 52 weeks is 73.72.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Bristol Myers Squibb Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2023 |
72.5663 |
71.6918 |
74.5300 |
71.0100 |
74.5300 |
4.41% |
| 2022 |
71.4692 |
59.5338 |
80.4921 |
59.5338 |
71.3842 |
19.00% |
| 2021 |
59.8923 |
57.6919 |
66.1344 |
51.5966 |
59.9860 |
2.89% |
| 2020 |
55.9258 |
57.7134 |
61.4401 |
42.2782 |
58.3029 |
0.39% |
| 2019 |
44.8478 |
45.8132 |
58.0753 |
38.3782 |
58.0753 |
27.86% |
| 2018 |
49.9655 |
52.1781 |
59.0859 |
42.6063 |
45.4200 |
-12.91% |
| 2017 |
48.5208 |
49.2530 |
55.6163 |
39.0451 |
52.1525 |
7.72% |
| 2016 |
51.8571 |
54.5381 |
63.1641 |
40.7859 |
48.4162 |
-13.50% |
| 2015 |
51.7686 |
47.3215 |
57.2195 |
46.0799 |
55.9701 |
19.24% |
| 2014 |
40.8318 |
40.4281 |
48.4430 |
36.2864 |
46.9398 |
14.18% |
| 2013 |
33.3319 |
24.5372 |
41.3623 |
24.5372 |
41.1087 |
69.95% |
| 2012 |
24.3426 |
24.9753 |
26.5615 |
22.8673 |
24.1884 |
-3.78% |
| 2011 |
20.3250 |
18.0984 |
25.1751 |
17.2175 |
25.1394 |
39.43% |
| 2010 |
17.1596 |
16.8301 |
18.7979 |
14.9116 |
18.0304 |
8.74% |
| 2009 |
13.8073 |
14.8373 |
16.8364 |
10.8795 |
16.5806 |
14.78% |
| 2008 |
12.9764 |
15.3294 |
15.8867 |
10.5807 |
14.4459 |
-6.05% |
| 2007 |
16.4753 |
14.8684 |
18.4603 |
14.7106 |
15.3758 |
4.75% |
| 2006 |
13.2277 |
12.3784 |
14.6788 |
11.1610 |
14.6788 |
19.92% |
| 2005 |
12.6791 |
12.9464 |
13.7827 |
11.2013 |
12.2400 |
-6.16% |
| 2004 |
12.5828 |
14.4351 |
15.0695 |
11.3219 |
13.0431 |
-7.27% |
| 2003 |
12.1051 |
11.3164 |
14.0662 |
9.9507 |
14.0662 |
29.02% |
| 2002 |
14.1195 |
22.9419 |
23.1450 |
9.4476 |
10.9020 |
-52.36% |
| 2001 |
25.5332 |
31.4812 |
31.4812 |
21.9862 |
22.8836 |
-29.71% |
| 2000 |
25.4584 |
27.9085 |
32.5555 |
18.9179 |
32.5555 |
17.10% |
| 1999 |
29.3677 |
27.8754 |
33.7553 |
24.7200 |
27.8003 |
-2.80% |
| 1998 |
23.1054 |
20.0115 |
28.6022 |
18.9923 |
28.6022 |
42.93% |
| 1997 |
15.9541 |
11.1046 |
20.5996 |
11.1046 |
20.0115 |
77.07% |
| 1996 |
9.3676 |
8.5270 |
11.9184 |
8.0812 |
11.3016 |
32.15% |
| 1995 |
6.7623 |
5.6878 |
8.5768 |
5.6040 |
8.5519 |
53.26% |
| 1994 |
5.2205 |
5.2575 |
5.7712 |
4.6945 |
5.5799 |
6.10% |
| 1993 |
5.1813 |
5.7756 |
5.7756 |
4.5591 |
5.2593 |
-9.48% |
| 1992 |
6.0859 |
7.3695 |
7.4113 |
5.2972 |
5.8100 |
-21.16% |
| 1991 |
6.5026 |
5.3954 |
7.3695 |
4.9702 |
7.3695 |
35.84% |
| 1990 |
4.6815 |
4.4336 |
5.4372 |
3.9842 |
5.4253 |
24.55% |
| 1989 |
3.7702 |
3.3150 |
4.4020 |
3.2866 |
4.3558 |
28.87% |
| 1988 |
3.1477 |
3.1953 |
3.3984 |
2.8443 |
3.3800 |
9.90% |
| 1987 |
3.5236 |
3.1166 |
4.0633 |
2.6966 |
3.0756 |
0.78% |
| 1986 |
2.7959 |
2.4288 |
3.2459 |
2.2304 |
3.0519 |
24.71% |
| 1985 |
2.1649 |
1.8931 |
2.4978 |
1.8377 |
2.4472 |
26.48% |
| 1984 |
1.7136 |
1.5932 |
1.9393 |
1.5422 |
1.9349 |
23.98% |
| 1983 |
1.4343 |
1.2375 |
1.7594 |
1.1636 |
1.5607 |
25.65% |
| 1982 |
1.0977 |
0.9743 |
1.3529 |
0.9444 |
1.2421 |
26.58% |
| 1981 |
0.9668 |
0.9420 |
1.0805 |
0.8520 |
0.9813 |
5.46% |
| 1980 |
0.7520 |
0.6719 |
0.9490 |
0.5679 |
0.9305 |
36.16% |
| 1979 |
0.6382 |
0.6579 |
0.7065 |
0.5772 |
0.6834 |
3.50% |
| 1978 |
0.6220 |
0.6165 |
0.7342 |
0.5218 |
0.6603 |
6.31% |
| 1977 |
0.6016 |
0.6280 |
0.6579 |
0.5333 |
0.6211 |
-2.00% |
| 1976 |
0.6752 |
0.6395 |
0.7642 |
0.5714 |
0.6338 |
-0.35% |
| 1975 |
0.5735 |
0.4721 |
0.6799 |
0.4351 |
0.6360 |
37.39% |
| 1974 |
0.4290 |
0.4317 |
0.5184 |
0.2920 |
0.4629 |
8.10% |
| 1973 |
0.5647 |
0.6326 |
0.6592 |
0.4063 |
0.4282 |
-32.80% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$158.293B |
$46.159B |
|
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
|
